HomeACXP • NASDAQ
add
Acurx Pharmaceuticals Inc
Previous close
$2.02
Day range
$1.99 - $2.19
Year range
$1.17 - $8.82
Market cap
33.75M USD
Avg Volume
30.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.38M | 50.81% |
Net income | -4.38M | -50.81% |
Net profit margin | — | — |
Earnings per share | -0.28 | -12.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.92M | 24.27% |
Total assets | 9.11M | 23.34% |
Total liabilities | 3.11M | 49.96% |
Total equity | 6.00M | — |
Shares outstanding | 15.84M | — |
Price to book | 5.32 | — |
Return on assets | -130.16% | — |
Return on capital | -205.24% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -4.38M | -50.81% |
Cash from operations | -3.06M | -58.46% |
Cash from investing | — | — |
Cash from financing | 4.51M | — |
Net change in cash | 1.45M | 174.85% |
Free cash flow | -1.42M | -68.33% |
About
CEO
Founded
2017
Website
Employees
4